Study: Black Stroke Patients Are More Likely to Be Misdiagnosed

By Jasmine Evans


Photo by Shutterstock

A new study from Johns Hopkins University shows that emergency-room physicians are more likely to misdiagnose Black stroke patients. In fact, Blacks and patients from other underrepresented groups are 30 percent more likely than whites to be misdiagnosed.

Researchers looked at emergency-room visit records across nine states and found that almost 14 percent of stroke admissions were misdiagnosed. The odds for misdiagnosis were higher for underrepresented groups, women and young people.

Stroke ranks among the leading causes of death in the United States, according to the Centers for Disease Control. About 800,000 Americans suffer a stroke every year, and almost 130,000 Americans die as a result of a stroke—that’s an average of one every four minutes, or one out of every 19 American deaths.

Blacks are nearly twice as likely as whites to suffer a stroke, and are also more likely to die as a result.

According to The Internet Stroke Center, stroke is also the leading cause of serious, long-term disability. When patients are misdiagnosed, the risk of death and disability increase significantly.

Traditional stroke symptoms include paralysis on one side of the body, trouble speaking and balance problems, according to Kaiser Permanente (No. 4 in the DiversityInc Top 50). Emergency-room doctors rarely miss these symptoms, but the study found that with nontraditional symptoms such as headaches and dizziness, the odds of misdiagnosis increase 43-fold.

Doctors currently diagnose strokes by focusing on age and vascular risk factors to determine the odds, meaning older male patients are less likely to be misdiagnosed. The research team from Johns Hopkins concluded that doctors need to find clinical symptoms that reliably identify strokes rather than depend on patient demographics. Solutions to this problem will most likely require new technology, scientific discoveries and improved training in diagnostics for doctors.

However, lapses in the diagnosis method do not explain why so many members of underrepresented groups are misdiagnosed. Blacks, specifically, are already more likely to have a stroke because of the prevalence of obesity in the Black community. So there must be a reason why many doctors aren’t considering stroke as a possibility when treating Blacks for stroke-related symptoms. Doctors may be unintentionally relying on an internal bias that causes them to believe the symptoms are due to another ailment rather than a stroke. Or, perhaps, members of underrepresented groups are more prone to nontraditional stroke symptoms. More research is needed into this issue in order to prevent future deaths and disabilities.

And the Hopkins researchers note that there is very little funding to find a solution to this issue. So patients have to advocate for themselves not only in the emergency room but also with Congressional representatives. The hope is that in the near future, improved technological and other diagnostic tools will reduce the number of misdiagnoses.

Latest News

Novartis Chief Medical Officer John Tsai on Balancing Medical Innovations With Patient Needs

Originally published at novartis.com by Elizabeth Dougherty. John Tsai is Novartis’ Head of Global Drug Development and Chief Medical Officer. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   John Tsai’s career as a physician, and now as Head of Global Drug Development and Chief Medical Officer for Novartis, had an unlikely…

Montgomery Mayor Steven Reed

City of Montgomery, Alabama Faces $25,000 State Fine for Changing Street Named After a Confederate Leader

Despite a state law designed to “protect” longstanding Confederate monuments and memorials, the city of Montgomery, Alabama, has decided that it would rather incur a fine than continue going on with a city street named after President of the Confederate States from 1861 to 1865, Jefferson Davis. Kim Chandler of…

Global Diversity

Despite Massive Uptick in Global DEI Initiatives, New Study Reveals Real Change in Corporate Workforces Remains Slow 

Even though DEI as a business imperative continues to grow both in the United States and around the world, a new study has found that many business leaders and executives have merely raised awareness of why diversity, equity and inclusion is important — as opposed to actually making meaningful progress…

Novartis Collaborates With Microsoft To Innovate Medicine Through Data and Artificial Intelligence

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   “We are not just discoverers. We actually create molecules that have never been made before.” Says Karin Briner, Head of Global Discovery Chemistry at Novartis Institutes for BioMedical Research (NIBR). By collaborating with Microsoft and augmenting the expertise of our…

Mastercard Announces Launch of Crescent City Card Program in Partnership With New Orleans and MoCaFi

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   New Orleans Mayor LaToya Cantrell was joined by executives from Mastercard, Mobility Capital Finance, Inc. (MoCaFi), and Forward Together New Orleans to announce the Crescent City Card Program. The program involves a…

Mastercard on Supporting Inclusive and Sustainable Urban Development by Expanding Its ‘City Possible’ Network

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Mastercard has continued to expand its support for addressing urban challenges and inequalities, working with city leaders and partners around the world, through the City Possible™ network and capabilities. The unique solutions…